Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR- γ in Mice
PPAR Research · 17.12.2019 · 2019 · 1-11
DOI: 10.1155/2019/2601408 ↗Kurz gefasst
Fachartikel in der Zeitschrift PPAR Research, erschienen am 17.12.2019. Verfasst von Jie Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Development Center for Medical Science and Technology.
Abstract (Originalsprache)
Background
Oxidative stress, inflammation and cardiac apoptosis were closely involved in doxorubicin (DOX)-induced cardiac injury. Piperine has been reported to suppress inflammatory response and pyroptosis in macrophages. However, whether piperine could protect the mice against DOX-related cardiac injury remain unclear. This study aimed to investigate whether piperine inhibited DOX-related cardiac injury in mice.
Methods
To induce DOX-related acute cardiac injury, mice in DOX group were intraperitoneally injected with a single dose of DOX (15 mg/kg). To investigate the protective effects of piperine, mice were orally treated for 3 weeks with piperine (50 mg/kg, 18:00 every day) beginning two weeks before DOX injection.
Results
Piperine treatment significantly alleviated DOX-induced cardiac injury, and improved cardiac function. Piperine also reduced myocardial oxidative stress, inflammation and apoptosis in mice with DOX injection. Piperine also improved cell viability, and reduced oxidative damage and inflammatory factors in cardiomyocytes. We also found that piperine activated peroxisome proliferator-activated receptor- γ (PPAR- γ ), and the protective effects of piperine were abolished by the treatment of the PPAR- γ antagonist in vivo and in vitro.
Conclusions
Piperine could suppress DOX-related cardiac injury via activation of PPAR- γ in mice.
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
ORCID-Profile: Chun-Yan Kong, Qi-Zhu Tang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Development Center for Medical Science and Technology
- National Health and Family Planning Commission of the People's Republic of China
- the Fundamental Research Funds for the Central Universities
- Guiding Fund of Renmin Hospital of Wuhan University
Zitieren
APA
Yan, J., Xu, S. C., Kong, C. Y., Zhou, X. Y., Bian, Z. Y., Yan, L., & Tang, Q. Z. (2019). Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR- γ in Mice. PPAR Research, 2019, 1-11. https://doi.org/10.1155/2019/2601408
Vancouver
Yan J, Xu SC, Kong CY, Zhou XY, Bian ZY, Yan L, et al. Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR- γ in Mice. PPAR Research. 2019;2019:1-11. doi:10.1155/2019/2601408
BibTeX
@article{Yan2019,
author = {Yan, Jie and Xu, Si-Chi and Kong, Chun-Yan and Zhou, Xiao-Yang and Bian, Zhou-Yan and Yan, Ling and Tang, Qi-Zhu},
title = {Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR- γ in Mice},
journal = {PPAR Research},
year = {2019},
volume = {2019},
pages = {1--11},
doi = {10.1155/2019/2601408}
}
EUVIMED